CD19+B cells are thought to promote breast cancer development and metastasis through the secretion of IL-10 and induction of the conversion of CD4+T cells to Treg in the mouse models (Olkhanud et al. 2011; Gray et al. 2007). Here, CD19 is linked to breast carcinoma.